Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Novel RANKL inhibitor reduces bone resorption in vivo

June 12, 2012

MABEL dose set for NKG2-A-directed monoclonal antibody

June 11, 2012

Ongoing EULAR conference features long-term adalimumab efficacy data in spondylarthritis

June 8, 2012

Auxilium planning sBLA for Xiaflex in new indication

June 4, 2012

Chelsea Therapeutics reports on preliminary analysis of phase II trial in RA

June 1, 2012

New immunomodulating fusion proteins presented by MIVAC Development

June 1, 2012

Flexion's lead osteoarthritis product relieves pain in phase II trial

May 31, 2012

Merck & Co. describes novel protein kinase inhibitors

May 25, 2012

New AP-TNAP inhibitors presented in France

May 23, 2012

Lupin designs new CRAC channel modulators

May 22, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Combination locked out in ATTR-CM? ‘Dead,’ expert says
BioWorld
The synergy – or lack of it – between knockdown drugs and stabilizers in treating transthyretin (TTR)-mediated amyloid cardiomyopathy (ATTR-CM) became one of the...